Optimizing drug therapy for older adults: shifting away from problematic polypharmacy.
Journal:
Expert opinion on pharmacotherapy
PMID:
38940370
Abstract
INTRODUCTION: The accelerated discovery and production of pharmaceutical products has resulted in many positive outcomes. However, this progress has also contributed to problematic polypharmacy, one of the rapidly growing threats to public health in this century. Problematic polypharmacy results in adverse patient outcomes and imposes increased strain and financial burden on healthcare systems.